Raymond Huml | Vice President, Rare & Orphan Strategy
Sciensus

Raymond A. Huml, MS, DVM, RAC, is an executive leader in the healthcare and biopharmaceutical industries, currently serving as the Vice President of Rare & Orphan Disease Strategy at Sciensus, a European life sciences company focused on enhancing patient access, engagement and insights, with a focus on rare diseases. In this position, Dr. Huml aims to bridge critical gaps for American companies seeking rare disease therapy approval and distribution across European markets. By leveraging over seventy million patient interactions, he helps develop innovative support programs and generate real-world insights to improve healthcare outcomes. Dr. Huml's career spans over three decades in the Contract Research Organization (CRO) sector, marked by notable leadership roles, including Global Head of Rare Disease Consortium, Head of Global Biosimilars Center of Excellence and Head of Global Due Diligence. His strategic insights have driven nearly $3.0 billion in capital commitments for transformative partnerships, including rare disease research, advancing innovation and collaboration in this critical field. A prolific author and thought leader, Dr. Huml has penned over one hundred articles, contributed to numerous book chapters, and authored four books on topics ranging from due diligence to rare disease drug development. His expertise has been recognized through awards such as the North Carolina Veterinary Medical Association's Young Veterinarian of the Year Award, the Triangle Business Journal’s Leaders in Diversity Award, and the Regulatory Affairs Professionals Society’s New Professional Award. Dr. Huml's commitment to advancing rare disease research and fostering diversity extends beyond his professional endeavors. As a Returned Peace Corps Volunteer who served in Ghana, West Africa, and as a former member of North Carolina State University’s Board of Visitors, he continues to make a positive impact on a global scale. Dr. Huml holds a Master of Science in Biology from East Stroudsburg University and earned his Doctor of Veterinary Medicine (DVM) from North Carolina State University’s College of Veterinary Medicine and is a certified Regulatory Affairs Professional (RAC-US).